- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05374135
Effect of Dexamethasone on Fetal Heart Rate Variables In Case Of Imminent Preterm Labor
May 10, 2022 updated by: Ereny Wagih Youssif, Assiut University
Effect of dexamethasone on fetal heart rate variability in case of preterm labour: prospective cohort study
Study Overview
Status
Recruiting
Detailed Description
prospective cohort study on Effect of dexamethasone on fetal heart rate variability in case of preterm labour
Study Type
Observational
Enrollment (Anticipated)
97
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ereny W Youssif, Master
- Phone Number: 01004252510
- Email: Erenywagih@gmail.com
Study Contact Backup
- Name: Tarek A Abdelradi, Professor
Study Locations
-
-
-
Assiut, Egypt
- Recruiting
- Assiut University
-
Contact:
- Assiut University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 46 years (Child, Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Pregnant women
Description
Inclusion Criteria:
- Preterm labor
Exclusion Criteria:
- Twins
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in fetal heart rate variability in relation to dexamethasone administration
Time Frame: Baseline
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tarek Kh Al-Hussini, Assiut University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2021
Primary Completion (Actual)
December 30, 2021
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
May 10, 2022
First Submitted That Met QC Criteria
May 10, 2022
First Posted (Actual)
May 16, 2022
Study Record Updates
Last Update Posted (Actual)
May 16, 2022
Last Update Submitted That Met QC Criteria
May 10, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Dexamethasone effect on FHR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.